We Compare Administration of 0.5% Bupivacaine and 0.75% Ropivacaine Intrathecally to patients undergoing Short Urological procedures.

Comparison of Intrathecal 0.5 percent Hyperbaric Bupivacaine And Intrathecal 0.75 percent Hyperbaric Ropivacaine In Short Urological Procedures: A Comparative Randomised Double Blind Study. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069296

Enrollment

Registered

2024-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N219- Calculus of lower urinary tract, unspecified Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Group Ropivacaine 0.75%: An anaesthesiologist experienced in performing subarachnoid block who is blinded to the study group will be performing this block.The patient selected as per th

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group:18 -65, of either sex. 2.ASA Class 1, 2 and 3. 3.Urological procedures lasting less than 45mins

Exclusion criteria

Exclusion criteria: 1.Patient refusal 2.Patients with significant coagulopathies and other contra-indications for sub arachnoid block. 3.Patients with pre-existing neurological deficit in lower part of the body. 4.Patients allergic to amide local anaesthetics.

Design outcomes

Primary

Measure	Time frame
Onset and duration of motor blockade. Onset and duration of sensory blockade. Timepoint: 9 months	—

Secondary

Measure	Time frame
Hemodynamic changes Adverse effects Time to ambulationTimepoint: 9 months	—

Countries

India

Contacts

Public ContactDr Imran Sholapur

SDM college of medical sciences

drimransholapur@gmail.com9731047204

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026